US biotech firm completes 95% of dodo genome, targets bird’s possible revival
Colossal Biosciences aims to resurrect the extinct dodo bird using cutting-edge gene-editing technologies. By leveraging their sophisticated AI platform, GenoMorph, the company has pinpointed essential genetic traits. With 95% of the dodo genome analysis complete, their ambitious project is on track, though a specific timeline for the living dodo remains undisclosed. This groundbreaking venture…
We haven't written up this one. Times of India has the full story — the link below goes straight to it.
